Details of the Drug | DrugMAP

General Information of Drug (ID: DMMFQUT)

Drug Name

PF-06273340

Indication

Disease Entry	ICD 11	Status	REF
Pain	MG30-MG3Z	Phase 1	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C23H22ClN7O3
Canonical SMILES: CC(C)(CO)N1C=C(C2=CN=C(N=C21)N)C(=O)C3=CC(=CN=C3)NC(=O)CC4=NC=C(C=C4)Cl
InChI: 1S/C23H22ClN7O3/c1-23(2,12-32)31-11-18(17-10-28-22(25)30-21(17)31)20(34)13-5-16(9-26-7-13)29-19(33)6-15-4-3-14(24)8-27-15/h3-5,7-11,32H,6,12H2,1-2H3,(H,29,33)(H2,25,28,30)
InChIKey: BPIWZDNVMQQBQX-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 66571548
CAS Number: 1402438-74-7
TTD ID: D0B4KU

References

1	ClinicalTrials.gov (NCT01601834) A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Oral Doses Of PF-06273340. U.S. National Institutes of Health.